Immunopathogenesis of viral ocular infections

Chemical Immunology

Volumn 73, Issue , 1999, Pages 120-136

  Hendricks, Robert L ^a  

^a University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2;

ANTIGEN PRESENTATION; AUTOIMMUNITY; CORNEA; CYTOMEGALIC INCLUSION BODY DISEASE; EYE INFECTION; HERPES SIMPLEX KERATITIS; HERPES ZOSTER; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

EID: 0032879029     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058743     Document Type: Review

References (20)

1. Doherty PC, Allan W, Eichelberger M, Carding SR: Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol 1992;10:123-151.
2. Doherty PC, Allan JE, Lynch F, Ceredig R: Dissection of an inflammatory process induced by CD8+ T cells. Immunol Today 1990;11:55-59.
3. Gordon YJ, Aoki K, Kinchington PR: Adenovirus keratoconjunctivitis; in Pepose JS, Holland GN, Wilhelmus KR (eds): Ocular Infection and Immunity. St Louis, Mosby Year Book, 1998, pp 877-894.
4. Bigger JE, Thomas CA, Atherton SS: NK cell modulation of murine cytomegalovirus retinitis. J Immunol 1998;160:5826-5831.
5. Shanley JD: In vivo administration of monoclonal antibody to the NK 1.I antigen of natural killer cells: Effect on acute murine cytomegalovirus infection. J Med Virol 1990;30:58-60.
6. Quinnan GV, Ennis FA: Cell-mediated immunity in cytomegalovirus infections - A review. Comp Immunol Microbiol Infect Dis 1980;3:283-290.
7. Pavan-Langston D, Dunkel EC: Varicella-zoster virus diseases: Anterior segment of the eye; in Pepose JS, Holland GN, Wilhelmus KR (eds): Ocular Infection and Immunity. St Louis, Mosby Year Book, 1996, pp 933-957.
8. Hoang-Xuan T, Buchi ER, Herbort CP, Denis J, Frot P, Thenault S, Pouliquen Y: Oral acyclovir for herpes zoster ophthalmicus. Ophthalmology 1992;99:1062-1070.
9. Mackensen G, Sundmacher R, Witschel H: Late wound complications after circular keratotomy for zoster keratitis. Cornea 1984;3:95-98.
10. Cantin EM, Hinton DR, Chen J, Openshaw H: Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol 1995;69:4898-4905.
11. Gebhardt BM, Hill JM: Cellular neuroimmunologic responses to ocular herpes simplex virus infection. J Neuroimmunol 1992;28:227-236.
12. Gesser RM, Valyi-Nagy T, Fraser NW: Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes. Virology 1994;200: 791-795.
13. Ghiasi H, Cai S, Nesburn AB, Wechsler SL: Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection. Virology 1996;224:330-333.
14. Goldsmith K, Chen W, Johnson DC, Hendricks RL: Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CDS + T cell response. J Exp Med 1998;187:341-348.
15. Halford WP, Gebhardt BM, Carr DJJ: Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol 1996;157:3542-3549.
16. Liu T, Tang Q, Hendricks RL: Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol 1996;70:264-271.
17. Sciammas R, Kodukula P, Tang Q, Hendricks RL, Bluestone JA: T cell receptor-γ/δ cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J Exp Med 1997;185:1969-1975.
18. Shimeld C, Whiteland JL, Williams NA, Easty D, Hill TJ: Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: An in vivo study of virus antigen and immune cell infiltration. J Gen Virol 1996;77:2583-2590.
19. Simmons A, Tscharke DC: Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: Implications for the fate of virally infected neurons. J Exp Med 1992;175:1337-1344.
20. Azumi A, Atherton SS: Sparing of the ipsilateral retina after anterior chamber inoculation of HSV-1: Requirement for either CD4+ or CD8+ T cells. Invest Ophthalmol Vis Sci 1994;35: 3251-3259.